Učitavanje...
Biologics in inflammatory bowel disease: what are the data?
BACKGROUND: Over the last decade, biologics have gained an important place for the treatment of moderate to severe inflammatory bowel disease (IBD), and many randomized control trials have evaluated their efficacy. AIM: The goal of this review is to analyze the results of these trials and to highlig...
Spremljeno u:
| Izdano u: | United European Gastroenterol J |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4625751/ https://ncbi.nlm.nih.gov/pubmed/26535119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615590302 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|